• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替拉扎明(SR 4233)可阻断细胞周期进程并诱导细胞凋亡。

Tirapazamine (SR 4233) interrupts cell cycle progression and induces apoptosis.

作者信息

Lin P S, Ho K C, Yang S J

机构信息

Department of Radiation Oncology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.

出版信息

Cancer Lett. 1996 Aug 2;105(2):249-55. doi: 10.1016/0304-3835(96)04292-9.

DOI:10.1016/0304-3835(96)04292-9
PMID:8697451
Abstract

Tirapazamine (Tira), a bioreductive agent, is highly toxic to cells under low oxygen conditions. Since active investigations of this agent are focusing on its potential as an adjunct of radiotherapy to improve overall effects on radioresistant hypoxic tumor cells, understanding its toxic mechanisms under aerobic conditions is important to the clinical application of this agent. Tira-treated V79 Chinese hamster cells were tested for cytotoxicity by colony assay and growth inhibition by the MTT assay. The survival of V79 cells after being exposed to 100 microM of Tira for 2 h was about 78% of untreated controls. The mitotic cell counts of V79 cells approached zero after 4 h treatment of Tira at 100 microM or 3 h at 300 microM. The fragmentation pattern of DNA isolated from cells 2 h after 300 microM Tira treatment showed characteristics of apoptotic cells. The induction of apoptosis by Tira was also detected by flow cytometric analysis and microscopic observation. These effects of Tira may be part of underlying toxic mechanisms to cells (including normal cells) under aerobic conditions.

摘要

替拉扎明(Tira)是一种生物还原剂,在低氧条件下对细胞具有高度毒性。由于对该药物的积极研究主要集中在其作为放射治疗辅助剂以提高对放射抗拒的缺氧肿瘤细胞的总体疗效,了解其在有氧条件下的毒性机制对于该药物的临床应用至关重要。通过集落测定法检测替拉扎明处理的V79中国仓鼠细胞的细胞毒性,并通过MTT测定法检测其生长抑制情况。V79细胞在暴露于100微摩尔替拉扎明2小时后的存活率约为未处理对照组的78%。在100微摩尔替拉扎明处理4小时或300微摩尔处理3小时后,V79细胞的有丝分裂细胞计数接近零。在300微摩尔替拉扎明处理2小时后从细胞中分离的DNA片段化模式显示出凋亡细胞的特征。通过流式细胞术分析和显微镜观察也检测到替拉扎明诱导的细胞凋亡。替拉扎明的这些作用可能是其在有氧条件下对细胞(包括正常细胞)潜在毒性机制的一部分。

相似文献

1
Tirapazamine (SR 4233) interrupts cell cycle progression and induces apoptosis.替拉扎明(SR 4233)可阻断细胞周期进程并诱导细胞凋亡。
Cancer Lett. 1996 Aug 2;105(2):249-55. doi: 10.1016/0304-3835(96)04292-9.
2
Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine.通过测量暴露于生物还原药物的球体和小鼠肿瘤中单个细胞的DNA损伤来检测缺氧。I. 替拉扎明。
Br J Cancer. 1995 Mar;71(3):529-36. doi: 10.1038/bjc.1995.105.
3
Use of the comet assay to identify cells sensitive to tirapazamine in multicell spheroids and tumors in mice.使用彗星试验鉴定多细胞球体和小鼠肿瘤中对替拉扎明敏感的细胞。
Cancer Res. 1996 Oct 1;56(19):4460-3.
4
Protection against SR 4233 (Tirapazamine) aerobic cytotoxicity by the metal chelators desferrioxamine and tiron.金属螯合剂去铁胺和替诺对SR 4233(替拉扎明)需氧细胞毒性的防护作用
Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):879-85. doi: 10.1016/0360-3016(94)90364-6.
5
Assessment of micronucleus induction in SCCVII cells treated with bioreductive agents, WIN 59075 (SR 4233) and mitomycin C, under aerobic and hypoxic conditions.在有氧和缺氧条件下,评估用生物还原药物WIN 59075(SR 4233)和丝裂霉素C处理的SCCVII细胞中的微核诱导情况。
Mutat Res. 1995 Apr;342(3-4):171-7. doi: 10.1016/0165-1218(95)90026-8.
6
Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.生物还原化合物THNLA-1在体外增强美法仑作用的相关机制。
Oncol Res. 1999;11(8):345-57.
7
LET dependency of heavy-ion induced apoptosis in V79 cells.V79细胞中重离子诱导凋亡的LET依赖性。
J Radiat Res. 2000 Jun;41(2):163-75. doi: 10.1269/jrr.41.163.
8
Effect of radiation and tirapazamine (SR-4233) on three melanoma cell lines.辐射和替拉扎明(SR-4233)对三种黑色素瘤细胞系的影响。
Melanoma Res. 1998 Dec;8(6):510-5. doi: 10.1097/00008390-199812000-00006.
9
Use of the comet assay to detect hypoxic cells in murine tumours and normal tissues exposed to bioreductive drugs.
Acta Oncol. 1995;34(3):301-5. doi: 10.3109/02841869509093979.
10
Activation of a well-behaved cell cycle in araC-treated V79 cells by caffeine.咖啡因对阿糖胞苷处理的V79细胞中正常细胞周期的激活作用。
Mutat Res. 1988 Mar-Apr;207(3-4):171-7. doi: 10.1016/0165-7992(88)90083-8.

引用本文的文献

1
5-Aminolaevulinic Acid-Mediated Photodynamic Therapy Combined with Tirapazamine Enhances Efficacy in Ovarian Cancer.5-氨基乙酰丙酸介导的光动力疗法联合替拉扎明可提高卵巢癌治疗效果。
Biomedicines. 2025 Mar 16;13(3):724. doi: 10.3390/biomedicines13030724.
2
Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy.靶向缺氧:癌症治疗中的缺氧激活前药
Front Oncol. 2021 Jul 29;11:700407. doi: 10.3389/fonc.2021.700407. eCollection 2021.
3
Biological evaluation of the toxicity and the cell cycle interruption by some benzimidazole derivatives.
某些苯并咪唑衍生物的毒性及细胞周期阻断的生物学评价
Tumour Biol. 2016 Aug;37(8):11135-45. doi: 10.1007/s13277-016-4828-1. Epub 2016 Mar 1.
4
Synthesis and antitumor evaluation of novel bis-triaziquone derivatives.新型双三嗪醌衍生物的合成与抗肿瘤评价
Molecules. 2009 Jun 29;14(7):2306-16. doi: 10.3390/molecules14072306.
5
Antitumor activities of D-glucosamine and its derivatives.D-葡萄糖胺及其衍生物的抗肿瘤活性。
J Zhejiang Univ Sci B. 2006 Aug;7(8):608-14. doi: 10.1631/jzus.2006.B0608.